Tolero Pharmaceuticals, Inc. – Product Pipeline Review

Global Markets Direct’s, ‘Tolero Pharmaceuticals, Inc. – Product Pipeline Review – 2016’, provides an overview of the Tolero Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Tolero Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Tolero Pharmaceuticals, Inc.

The report provides overview of Tolero Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Tolero Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Tolero Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Tolero Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Tolero Pharmaceuticals, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Tolero Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Tolero Pharmaceuticals, Inc. Snapshot 5

Tolero Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Tolero Pharmaceuticals, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Tolero Pharmaceuticals, Inc. - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Tolero Pharmaceuticals, Inc. - Pipeline Products Glance 11

Tolero Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Tolero Pharmaceuticals, Inc. - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Tolero Pharmaceuticals, Inc. - Drug Profiles 13

alvocidib hydrochloride 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

HCI-1680 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

HCI-1708 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

SGI-7079 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

TP-0158 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

TP-0184 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

TP-0413 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

TP-0903 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

TP-1101 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

TP-3654 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Tolero Pharmaceuticals, Inc. - Pipeline Analysis 24

Tolero Pharmaceuticals, Inc. - Pipeline Products by Target 24

Tolero Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 25

Tolero Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 26

Tolero Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 27

Tolero Pharmaceuticals, Inc. - Recent Pipeline Updates 28

Tolero Pharmaceuticals, Inc. - Dormant Projects 31

Tolero Pharmaceuticals, Inc. - Discontinued Pipeline Products 32

Discontinued Pipeline Product Profiles 32

SGI-1776 32

Tolero Pharmaceuticals, Inc. - Locations And Subsidiaries 33

Head Office 33

Appendix 34

Methodology 34

Coverage 34

Secondary Research 34

Primary Research 34

Expert Panel Validation 34

Contact Us 34

Disclaimer 35

List of Tables

List of Tables

Tolero Pharmaceuticals, Inc., Key Information 5

Tolero Pharmaceuticals, Inc., Key Facts 5

Tolero Pharmaceuticals, Inc. – Pipeline by Indication, 2016 7

Tolero Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2016 9

Tolero Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2016 10

Tolero Pharmaceuticals, Inc. – Phase II, 2016 11

Tolero Pharmaceuticals, Inc. – Preclinical, 2016 12

Tolero Pharmaceuticals, Inc. – Pipeline by Target, 2016 24

Tolero Pharmaceuticals, Inc. – Pipeline by Route of Administration, 2016 25

Tolero Pharmaceuticals, Inc. – Pipeline by Molecule Type, 2016 26

Tolero Pharmaceuticals, Inc. – Pipeline Products by Mechanism of Action, 2016 27

Tolero Pharmaceuticals, Inc. – Recent Pipeline Updates, 2016 28

Tolero Pharmaceuticals, Inc. – Dormant Developmental Projects,2016 31

Tolero Pharmaceuticals, Inc. – Discontinued Pipeline Products, 2016 32

List of Figures

List of Figures

Tolero Pharmaceuticals, Inc. – Pipeline by Top 10 Indication, 2016 7

Tolero Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2016 9

Tolero Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2016 10

Tolero Pharmaceuticals, Inc. – Pipeline by Top 10 Target, 2016 24

Tolero Pharmaceuticals, Inc. – Pipeline by Route of Administration, 2016 25

Tolero Pharmaceuticals, Inc. – Pipeline by Molecule Type, 2016 26

Tolero Pharmaceuticals, Inc. – Pipeline Products by Top 10 Mechanism of Action, 2016 27

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports